Ligand · QFE
QFE · (3~{R},4~{R})-~{N}4-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]oxane-3,4-diamine
QFE, (3~{R},4~{R})-~{N}4-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]oxane-3,4-diamine (C23 H24 N8 O, 428.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- QFE
- Formula
- C23 H24 N8 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
QFE in 2 structures; the first of them:
- 6ZCS · SYK Kinase domain in complex with azabenzimidazole inhibitor 3 · QFE A701 · binds LEU377, GLY378, SER379, PHE382, VAL385, ALA400, LYS402, VAL433 and 13 more
- 6ZCS · Syk kinase domain in complex with azabenzimidazole inhibitor 3 · QFE A701 · binds LEU377, SER379, VAL385, ALA400, LYS402, MET448, GLU449, MET450 and 9 more
Residues it binds most
LEU 2, ALA 2, GLU 2, MET 2, SER 2, GLY 2, VAL 2, ARG 2, ASN 2, ASP 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.